Close Menu

NEW YORK (GenomeWeb) – NIPD Genetics said today that it has signed a partnership agreement with Medicover covering NIPD Genetics' noninvasive prenatal tests, as well as the development of new tests.

The deal includes cooperation, investment, and a facility agreement that provides substantial capital to grow sales and research and development, according to Cyprus-based NIPD Genetics.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.